Literature DB >> 14284934

TECHNIQUES FOR STUDY OF RESISTANCE TO FOLIC ACID ANTAGONISTS.

J R BERTINO, G A FISCHER.   

Abstract

Entities:  

Keywords:  FOLIC ACID ANTAGONISTS; GUINEA PIGS; LIVER; NEOPLASMS; PHARMACOLOGY; REVIEW

Mesh：

Substances：

Year:  1964        PMID： 14284934

Source DB:  PubMed          Journal:  Methods Med Res        ISSN： 0094-9590


× No keyword cloud information.
  21 in total

1.  Potent antipneumocystis and antitoxoplasma activities of piritrexim, a lipid-soluble antifolate.

Authors:  J A Kovacs; C J Allegra; J C Swan; J C Drake; J E Parrillo; B A Chabner; H Masur
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

2.  Increase of dihydrofolate reductase activity in cultured mammalian cells after exposure to methotrexate.

Authors:  B L Hillcoat; V Swett; J R Bertino
Journal:  Proc Natl Acad Sci U S A       Date:  1967-10       Impact factor: 11.205

3.  Antineoplastic activity of lipid-soluble dialkyl esters of methotrexate.

Authors:  D G Johns; D Farquhar; B A Chabner; M K Wolpert; R H Adamson
Journal:  Experientia       Date:  1973-09-15

4.  Anisotropic membranes with carboxypeptidase G1.

Authors:  A M Pitt; S M Cramer; A B Czernicki; K Kalghatgi; C Horvath; B A Solomon
Journal:  Appl Biochem Biotechnol       Date:  1983-02       Impact factor: 2.926

5.  Mechanism of pyrimethamine resistance in recent isolates of Plasmodium falciparum.

Authors:  T F McCutchan; J A Welsh; J B Dame; I A Quakyi; P M Graves; J C Drake; C J Allegra
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

6.  Methotrexate-induced oral mucositis and salivary methotrexate concentrations.

Authors:  A Oliff; W A Bleyer; D G Poplack
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

7.  Competitive protein binding assay for methotrexate.

Authors:  C E Myers; M E Lippman; H M Elliot; B A Chabner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

8.  Methotrexate-vindesine association in the treatment of head and neck cancer influence of vindesine on methotrexate's pharmacokinetic behavior.

Authors:  N Lena; A M Imbert; T Pignon; R Favre; G Meyer; J P Cano; Y Carcassonne
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

9.  Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.

Authors:  B A Chabner; R C Young
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

10.  Methotrexate-vindesine association in leukemia: pharmacokinetic study.

Authors:  N Tubiana; N Lena; J Barbet; A M Imbert; C Lejeune; D Maraninchi; D Sainty; G Sebahoun; J A Gastaut; J P Cano
Journal:  Med Oncol Tumor Pharmacother       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.